Qtron Investments LLC Biogen Inc. Transaction History

Qtron Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $65,441 - $78,774	-294 Reduced 25.99%	837 $216,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $321,944 - $363,366	-1,271 Reduced 52.91%	1,131 $290,000
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $138,726 - $160,302	-504 Reduced 17.34%	2,402 $684,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $215,331 - $261,632	853 Added 41.55%	2,906 $804,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $399,698 - $551,148	2,053 New	2,053 $548,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $207,479 - $243,074	-854 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $58,356 - $87,840	-247 Reduced 22.43%	854 $209,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $98,494 - $113,724	-372 Reduced 25.25%	1,101 $312,000
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $396,016 - $502,351	1,473 New	1,473 $466,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Qtron Investments LLC with notifications on news.